U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 12

1.

Predictive Value of MicroRNAs in the Progression of Oral Leukoplakias

(Submitter supplied) Predictive Value of MicroRNAs in the Progression of Oral Leukoplakias
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL16791
20 Samples
Download data: TXT
Series
Accession:
GSE62809
ID:
200062809
2.

A three–microRNA signature as a potential biomarker for the early detection of oral cancer

(Submitter supplied) Background: Oral squamous cell carcinoma (OSCC) is often diagnosed at a late stage and may be malignantly transformed from oral leukoplakia (OL). This study aimed to identify potential plasma microRNAs (miRNAs) for the early detection of oral cancer. Methods: Plasma from normal, OL, and OSCC patients were evaluated. Small RNA sequencing was used to screen differently expressed miRNAs among the groups. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL18573
3 Samples
Download data: TXT
Series
Accession:
GSE104440
ID:
200104440
3.

Diagnostic value of a panel of plasma exosomal miRNAs as potential biomarkers for thyroid nodules

(Submitter supplied) Exosomes and exosomal miRNAs from the plasma of volunteers were isolated from thyroid nodules and papillary tyriod cancer patients . Profiling of exosomal miRNA was performed using next-generation sequencing(NGS) to identify miRNA candidates for diagnosis.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL11154
24 Samples
Download data: FA, TXT
Series
Accession:
GSE130512
ID:
200130512
4.

MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma

(Submitter supplied) The aim of our study was to discover a miR marker panel prognostic of 5-year survival in OSCC patients that may be utilized in parallel with the current clinical covariates. We assessed differential expression of miRNAs genome-wide via deep sequencing in 20 tumor tissue samples. We also attempted to identify deregulated miR expression signatures that may serve as the prognostic marker of cancer survival. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL16791
20 Samples
Download data: TXT
Series
Accession:
GSE52633
ID:
200052633
5.

microRNA profile in the cervical mucus of the cervical neoplasia

(Submitter supplied) Cervical mucus was collected from 86 patients with a normal cervix, cervical intraepithelial neoplasia (CIN), squamous cell carcinoma (SCC), or adenocarcinoma (AD). 76 candidates of miRNAs were selected according to criteria such as absolute value of the signal intensity included more than 20 and the ratio of the SCC/normal or AD/normal included more than four.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL21263
5 Samples
Download data: TXT
Series
Accession:
GSE105409
ID:
200105409
6.

Large-scale serum microRNA profiling for developing an esophageal squamous cell carcinoma detection model

(Submitter supplied) A serum miRNA combination could be a powerful classifier for the detection of esophageal squamous cell carcinoma.
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL21263
5531 Samples
Download data: TXT
Series
Accession:
GSE122497
ID:
200122497
7.

miRNA-Seq identifies a serum miRNA panel which can detect and monitor liver disease in pediatric cystic fibrosis

(Submitter supplied) Purpose: Cystic fibrosis (CF)-associated liver disease (CFLD) is a hepatobiliary complication of CF. Current diagnostic modalities rely on non-specific assessments, while liver biopsy is the gold standard to assess severity of disease. Using miRNA-sequencing we investigated the use of serum miRNA to diagnose and monitor CFLD progression in children with CF. Methods: This was a cross-sectional cohort study of the circulatory miRNA signature of 90 children grouped by clinical, biochemical and imaging assessments as follows: healthy controls (n=30), CF patients with no evidence of liver disease (CFnoLD, n=30) and CFLD (n=30). more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL17303
8 Samples
Download data: TXT
Series
Accession:
GSE111754
ID:
200111754
8.

Expression data of different types of OSAHS patients

(Submitter supplied) OSAHS is a complex,synthetical disease that can lead to multiple system and multiple organ damage as the disease progresses.Metabolic syndrome is the most common complication, but the symptoms at different stages of the disease are different.It is known that miRNAs can be stably in the serum and changes during the development of the disease.Therefore, we speculate that serum miRNAs could biomarkers for OSAHS diagnosis and progression judgment. more...
Organism:
synthetic construct; Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL21572
15 Samples
Download data: CEL
Series
Accession:
GSE112093
ID:
200112093
9.

Serum miRNA profiles for gastric cancer diagnosis

(Submitter supplied) Circulating microRNAs (miRNAs) in serum may serve as promising diagnostic biomarkers for patients with gastric cancer (GC). Using quantitative reverse transcription polymerase chain reaction (qRT-PCR) based Exiqon panel, we identified 58 differentially expressed miRNAs from 3 GC pool samples and 1 normal control (NC) pool in the initial screening phase. Identified miRNAs were further validated in the training (49 GC VS. more...
Organism:
Homo sapiens
Type:
Other
Platform:
GPL19066
4 Samples
Download data: TXT
Series
Accession:
GSE86226
ID:
200086226
10.

The prognostic and predictive value of a six-microRNA-based classifier in stage II colon cancer

(Submitter supplied) microRNA profiling of colon tumor tissues vs adjacent normal tissues
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL17496
80 Samples
Download data: GPR
Series
Accession:
GSE49246
ID:
200049246
11.

RNA-seq identifies circulating miR-125a-5p, miR-125b-5p and miR-143-3p as potential biomarkers for acute ischemic stroke

(Submitter supplied) Rationale: Currently, there are no blood-based biomarkers with clinical utility for acute ischemic stroke (IS). microRNAs (miRNAs) show promise as disease markers due to their cell-type specific expression patterns and stability in peripheral blood. Objective: To identify circulating miRNAs associated with acute IS, determine their temporal course up to 90 days post-stroke, and explore their utility as an early diagnostic marker. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL15456
40 Samples
Download data: CSV
Series
Accession:
GSE110993
ID:
200110993
12.

MiRNA-seq in blood of myasthenia gravis (MG) patients responder and non-responder to immunosuppressive treatment

(Submitter supplied) Purpose: to identify specific miRNAs as biomarkers associated with immunosuppressive treatment response in MG patients. Methods: Blood miRNome profiles of 15 responder and 15 non-responder MG patients by miRNA-seq using Illumina NextSeq 500 sequencing. Raw data were de-multiplexed and FASTQ files for each sample were generated using the bcl2fastq software. FASTQ data were checked using the FastQC tool. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL18573
30 Samples
Download data: XLSX
Series
Accession:
GSE131703
ID:
200131703
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_66702b86909a3d46addc4f8e|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center